BIOMAT Database Logo BIOMAT Database Logo

A double blind trial of LB-46 in the treatment of angina pectoris. 1973

B Raychaudhuri, and M R Das, and C Neelakatan, and N D Chaudhuri, and J Bose, and M K Chetri

UI MeSH Term Description Entries
D007211 Indoles Benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl portion, in contrast to ISOINDOLES which have the nitrogen away from the six-membered ring.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D011433 Propranolol A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs. Dexpropranolol,AY-20694,Anaprilin,Anapriline,Avlocardyl,Betadren,Dociton,Inderal,Obsidan,Obzidan,Propanolol,Propranolol Hydrochloride,Rexigen,AY 20694,AY20694,Hydrochloride, Propranolol
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000787 Angina Pectoris The symptom of paroxysmal pain consequent to MYOCARDIAL ISCHEMIA usually of distinctive character, location and radiation. It is thought to be provoked by a transient stressful situation during which the oxygen requirements of the MYOCARDIUM exceed that supplied by the CORONARY CIRCULATION. Angor Pectoris,Stenocardia,Stenocardias
D013565 Sympatholytics Drugs that inhibit the actions of the sympathetic nervous system by any mechanism. The most common of these are the ADRENERGIC ANTAGONISTS and drugs that deplete norepinephrine or reduce the release of transmitters from adrenergic postganglionic terminals (see ADRENERGIC AGENTS). Drugs that act in the central nervous system to reduce sympathetic activity (e.g., centrally acting alpha-2 adrenergic agonists, see ADRENERGIC ALPHA-AGONISTS) are included here. Sympathetic-Blocking Agents,Sympatholytic,Sympatholytic Agent,Sympatholytic Drug,Sympatholytic Agents,Sympatholytic Drugs,Sympatholytic Effect,Sympatholytic Effects,Agent, Sympatholytic,Agents, Sympathetic-Blocking,Agents, Sympatholytic,Drug, Sympatholytic,Drugs, Sympatholytic,Effect, Sympatholytic,Effects, Sympatholytic,Sympathetic Blocking Agents

Related Publications

B Raychaudhuri, and M R Das, and C Neelakatan, and N D Chaudhuri, and J Bose, and M K Chetri
A double blind drug trial of LB-46 (visken) in angina pectoris.
June 1972, Indian heart journal,
B Raychaudhuri, and M R Das, and C Neelakatan, and N D Chaudhuri, and J Bose, and M K Chetri
A double blind study of Visken LB-46, in the treatment of angina pectoris.
June 1972, Indian heart journal,
B Raychaudhuri, and M R Das, and C Neelakatan, and N D Chaudhuri, and J Bose, and M K Chetri
A new beta receptor blocking agent LB-46 in angina pectoris. (A double blind clinical trial).
June 1972, Indian heart journal,
B Raychaudhuri, and M R Das, and C Neelakatan, and N D Chaudhuri, and J Bose, and M K Chetri
Nialamide treatment of angina pectoris. A double-blind trial.
March 1961, Acta medica Scandinavica,
B Raychaudhuri, and M R Das, and C Neelakatan, and N D Chaudhuri, and J Bose, and M K Chetri
Practolol in treatment of angina pectoris. A double-blind trial.
May 1970, British medical journal,
B Raychaudhuri, and M R Das, and C Neelakatan, and N D Chaudhuri, and J Bose, and M K Chetri
Trasicor in angina pectoris: a double-blind trial.
April 1969, British medical journal,
B Raychaudhuri, and M R Das, and C Neelakatan, and N D Chaudhuri, and J Bose, and M K Chetri
[LB-46 in the treatment of angina pectoris, arrhythmia and functional cardiac disorders].
September 1976, Minerva cardioangiologica,
B Raychaudhuri, and M R Das, and C Neelakatan, and N D Chaudhuri, and J Bose, and M K Chetri
A double-blind trial of hexobendine in the treatment of angina pectoris.
August 1968, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
B Raychaudhuri, and M R Das, and C Neelakatan, and N D Chaudhuri, and J Bose, and M K Chetri
[Use of LB-46 in angina pectoris and cardiac arrhythmias].
February 1972, Arquivos brasileiros de cardiologia,
B Raychaudhuri, and M R Das, and C Neelakatan, and N D Chaudhuri, and J Bose, and M K Chetri
[Results in the treatment of angina pectoris using the beta blockader LB 46(Visken)].
August 1973, Vnitrni lekarstvi,
Copied contents to your clipboard!